CIA BRASILEIRA DE DIS- ADR (CBD) Stock Analyst Ratings
USA - NYSE:CBD - US20440T3005 - ADR
0.445 USD
-0.01 (-3.05%)
0.4357 USD
-0.01 (-2.09%)
ChartMill assigns a Buy % Consensus number of 50% to CBD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 244.19% above the current price.
CBD was analyzed by 16 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about CBD.
In the previous month the buy percentage consensus was at a similar level.
CBD was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-04 | B of A Securities | Upgrade | Underperform -> Buy |
CIA BRASILEIRA DE DIS- ADR / CBD FAQ
Can you provide the average price target for CIA BRASILEIRA DE DIS- ADR stock?
16 analysts have analysed CBD and the average price target is 1.53 USD. This implies a price increase of 244.19% is expected in the next year compared to the current price of 0.445.
What is the consensus rating for CIA BRASILEIRA DE DIS- ADR (CBD) stock?
The consensus rating for CIA BRASILEIRA DE DIS- ADR (CBD) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for CBD stock?
The number of analysts covering CIA BRASILEIRA DE DIS- ADR (CBD) is 16.